Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2022-02-11 Major Shareholding Noti…
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
SC 13G
Major Shareholding Notification
2022-02-11 English
10-K
Annual Report FY 2021
2022-02-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 10, 2022, reporting the issuance of a press release announcing financial results for the quarter ended December 31, 2021. The text explicitly states that the press release is furnished as an exhibit and is a summary announcement of quarterly financial results. The document length is 3576 characters, which is relatively short and primarily serves as an announcement rather than containing detailed financial statements or analysis. According to the rules, such a document announcing quarterly financial results is classified as an Earnings Release (ER).
2022-02-10 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text describes an amendment and restatement of a standstill agreement between DaVita Inc. and Berkshire Hathaway Inc., which relates to ownership and voting rights. There are no financial statements or detailed financial data presented, nor is this an earnings release or annual/interim report. The document is not a proxy solicitation, dividend notice, or merger filing. It is a regulatory announcement of a corporate agreement event. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is under 5,000 characters and contains detailed event information, not just a report publication announcement. Confidence is high due to clear identification as a Form 8-K current report with a specific corporate event disclosed.
2022-02-09 English
SCHEDULE 13G/A
Major Shareholding Notification
2022-02-09 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.